Principal Investigator
Ruham Nasany
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20241080
Clinical Trial Summary
Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma
Phase
Phase II
Funding Agency/Sponsor
Externally Peer-Reviewed
Disease
Neurological Cancer
Contact Information
Phone Number
+1 (305) 2437261